share_log

HC Wainwright & Co. Reiterates Buy on Reneo Pharmaceuticals, Maintains $30 Price Target

HC Wainwright & Co. Reiterates Buy on Reneo Pharmaceuticals, Maintains $30 Price Target

HC Wainwright & Co.重申買入瑞諾製藥,維持30美元的目標股價
Benzinga ·  2023/11/14 06:29

HC Wainwright & Co. analyst Mitchell Kapoor reiterates Reneo Pharmaceuticals (NASDAQ:RPHM) with a Buy and maintains $30 price target.

HC Wainwright & Co. 分析師米切爾·卡普爾重申瑞諾製藥(納斯達克股票代碼:RPHM)的買入並維持30美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論